Messages in brief
Austrian Medicines Agency is a member of ICMRA
The International Coalition of Medicines Regulatory Agencies (ICMRA) admitted the Federal Office for Healthcare Safety/AGES Medical Market…
Recall of "EpiPen 300 micrograms solution for injection in a ready-to-use pen".
EpiPen 300 micrograms solution for injection in a ready-to-use pen (epinephrine) has been approved under the MRP/DCP procedure since March 30, 1998…
Drug regulatory authorities: Cooperation between Switzerland and Austria
Swissmedic , the Swiss Agency for Therapeutic Products, wants to work more closely with its partner authority in Austria. Swissmedic Director Jürg…
Reminder: private sale of medicines prohibited
Due to current events (see screenshot), the Federal Office for Safety in Health Care points out that according to §59 of the Medicines Act, private…
Possible interactions with "morning-after pill" - double dose or copper IUD required
New recommendations for levonorgestrel emergency contraceptives in case of interactions with CYP3A4-inducing drugs.
In Austria, the current…
Information on reporting according to the Antibiotics Quantitative Flows Regulation
Information on user registration and submission of sales and delivery notifications as well as ways to contact us can be found here.
Please note the…
Successful action against illegal cell therapies
Stem cell and other cell therapies are associated with great hopes, both among physicians and patients. Great progress is expected, especially in the…
Clinical research: Strengthening the research location with Pilot
EU Regulation 536/2014 is expected to standardize the approval procedure for clinical trials throughout the EU from fall 2018. These are an essential…
AGES launches social media campaign to report adverse reactions
AGES Medical Market Surveillance launches a social media campaign from November 7 - 11, 2016 to increase willingness to report adverse reactions.
Vie…
